Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 712

1.

Intensity-modulated radiotherapy vs. parotid-sparing 3D conformal radiotherapy. Effect on outcome and toxicity in locally advanced head and neck cancer.

Lambrecht M, Nevens D, Nuyts S.

Strahlenther Onkol. 2013 Mar;189(3):223-9. doi: 10.1007/s00066-012-0289-7. Epub 2013 Jan 16.

PMID:
23319256
2.

Toxicity and outcome of intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy for oropharyngeal cancer: a matched-pair analysis.

Al-Mamgani A, Van Rooij P, Tans L, Teguh DN, Levendag PC.

Technol Cancer Res Treat. 2013 Apr;12(2):123-30. doi: 10.7785/tcrt.2012.500305. Epub 2012 Oct 19.

PMID:
23098281
3.

Xerostomia after radiotherapy. What matters--mean total dose or dose to each parotid gland?

Tribius S, Sommer J, Prosch C, Bajrovic A, Muenscher A, Blessmann M, Kruell A, Petersen C, Todorovic M, Tennstedt P.

Strahlenther Onkol. 2013 Mar;189(3):216-22. doi: 10.1007/s00066-012-0257-2. Epub 2013 Jan 27.

PMID:
23354440
4.

3D-conformal-intensity modulated radiotherapy with compensators for head and neck cancer: clinical results of normal tissue sparing.

Wendt TG, Abbasi-Senger N, Salz H, Pinquart I, Koscielny S, Przetak SM, Wiezorek T.

Radiat Oncol. 2006 Jun 21;1:18.

5.

Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70-75 Gy in 5 weeks for advanced head and neck cancer. A phase I dose escalation study.

Cvek J, Kubes J, Skacelikova E, Otahal B, Kominek P, Halamka M, Feltl D.

Strahlenther Onkol. 2012 Aug;188(8):666-70. doi: 10.1007/s00066-012-0128-x. Epub 2012 Jun 1.

PMID:
22648405
6.

Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.

Vergeer MR, Doornaert PA, Rietveld DH, Leemans CR, Slotman BJ, Langendijk JA.

Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):1-8. doi: 10.1016/j.ijrobp.2008.07.059. Epub 2008 Dec 26.

PMID:
19111400
7.

Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.

Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):374-87.

PMID:
15380569
8.

Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.

Sultanem K, Shu HK, Xia P, Akazawa C, Quivey JM, Verhey LJ, Fu KK.

Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):711-22.

PMID:
11020568
9.

Submandibular gland-sparing radiation therapy for locally advanced oropharyngeal squamous cell carcinoma: patterns of failure and xerostomia outcomes.

Gensheimer MF, Liao JJ, Garden AS, Laramore GE, Parvathaneni U.

Radiat Oncol. 2014 Nov 26;9:255. doi: 10.1186/s13014-014-0255-x.

10.

Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma.

Refaat T, Choi M, Thomas TO, Bacchus I, Agulnik M, Pelzer HJ, Mellott AL, Rademaker AW, Liu D, Sathiaseelan V, Mittal BB.

Am J Clin Oncol. 2015 Dec;38(6):588-94. doi: 10.1097/COC.0000000000000001.

PMID:
24136140
11.

Intensity modulated radiation therapy for oropharyngeal and oral cavity tumors: clinical use and experience.

Claus F, Duthoy W, Boterberg T, De Gersem W, Huys J, Vermeersch H, De Neve W.

Oral Oncol. 2002 Sep;38(6):597-604.

PMID:
12167438
12.

The impact of treatment modality and radiation technique on outcomes and toxicity of patients with locally advanced oropharyngeal cancer.

Al-Mamgani A, van Rooij P, Verduijn GM, Mehilal R, Kerrebijn JD, Levendag PC.

Laryngoscope. 2013 Feb;123(2):386-93. doi: 10.1002/lary.23699.

PMID:
23404489
13.

Conventional 2D (2DRT) and 3D conformal radiotherapy (3DCRT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer treatment.

Moretto F, Rampino M, Munoz F, Ruo Redda MG, Reali A, Balcet V, Badellino S, Piva C, Schena M, Airoldi M, Ostellino O, Pecorari G, Ragona R, Ricardi U.

Radiol Med. 2014 Aug;119(8):634-41. doi: 10.1007/s11547-013-0359-7. Epub 2014 Jan 15.

PMID:
24424659
14.

Can dose reduction to one parotid gland prevent xerostomia?--A feasibility study for locally advanced head and neck cancer patients treated with intensity-modulated radiotherapy.

Anand AK, Jain J, Negi PS, Chaudhoory AR, Sinha SN, Choudhury PS, Kumar R, Munjal RK.

Clin Oncol (R Coll Radiol). 2006 Aug;18(6):497-504.

PMID:
16909975
15.

Comparison of IMRT techniques in the radiotherapeutic management of head and neck cancer: is tomotherapy "better" than step-and-shoot IMRT?

Chen AM, Marsano J, Perks J, Farwell G, Luu Q, Donald PJ, Purdy JA.

Technol Cancer Res Treat. 2011 Apr;10(2):171-7.

PMID:
21381795
16.
17.

Effect of radiation techniques in treatment of oropharynx cancer.

Rusthoven KE, Raben D, Ballonoff A, Kane M, Song JI, Chen C.

Laryngoscope. 2008 Apr;118(4):635-9. doi: 10.1097/MLG.0b013e31815fdf0e.

PMID:
18176348
18.
19.

Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.

Kam MK, Teo PM, Chau RM, Cheung KY, Choi PH, Kwan WH, Leung SF, Zee B, Chan AT.

Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1440-50.

PMID:
15590175
20.

[SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].

Kiprian D, Jarząbski A, Pawłowska B, Michalski W, Kawecki A.

Otolaryngol Pol. 2011 Sep;65(5 Suppl):117-25. Polish.

PMID:
22000261
Items per page

Supplemental Content

Write to the Help Desk